---
figid: PMC4084561__nihms594043f3
figlink: /pmc/articles/PMC4084561/figure/F3/
number: Figure 3
caption: 'Various receptor pathways cross-regulate the type I interferon (IFN) response;
  this alters the expression levels and activation states of IFN signalling components.
  Various mitogen-activated protein kinase (MAPK)-activating pathways, such as those
  induced by pattern-recognition receptors (PRRs), enhance signal transducer and activator
  of transcription 1 (STAT1) transcriptional activity through phosphorylation of a
  conserved carboxy-terminal serine. Low-level basal signalling by immunoreceptor
  tyrosine-based activation motif (ITAM)-containing receptors also augments Janus
  kinase 1 (JAK1) activity through activation of spleen tyrosine kinase (SYK) and
  protein tyrosine kinase 2 (PYK2). Conversely, strong activation of ITAM-containing
  receptors by high-avidity crosslinking suppresses IFNα receptor (IFNAR) signalling
  via protein kinase C (PKC)-mediated recruitment of SH2 domain-containing protein-tyrosine
  phosphatase 2 (SHP2), which dephosphorylates signalling intermediates. Cytokine
  signalling pathways, including the interleukin-1 (IL-1) pathway, inhibit type I
  IFN responses by directly promoting IFN receptor turnover via p38 kinase and casein
  kinase II (CK2). Various cytokines that signal through JAK–STAT pathways, including
  type I IFNs, regulate the expression levels of both positive and negative regulators
  of the IFN response pathways. JAK–STAT-induced positive regulators include STAT1
  and IFN-regulatory factor 9 (IRF9), whereas negative regulators include the suppressor
  of cytokine signalling (SOCS) protein family and ubiquitin carboxy-terminal hydrolase
  18 (USP18). Inhibitor of NF-κB kinase-ε (IKKε)-mediated STAT1 phosphorylation inhibits
  STAT1 homodimerization, thereby promoting activation of the IFN-stimulated gene
  factor 3 (ISGF3) complex rather than STAT1 homodimers in response to type I IFN.
  IKKε expression is induced by various pathways, including tumour necrosis factor
  (TNF)- and PRR-induced pathways. MicroRNAs induced by cytokine and PRR pathways
  downregulate the expression of IFN response signalling proteins: for example, miR-146a
  suppresses STAT1 expression, and miR-155 causes a collective reduction in various
  IFN signalling proteins. AGO2, Argonaute 2; RISC, RNA-induced silencing complex.'
pmcid: PMC4084561
papertitle: Regulation of type I interferon responses.
reftext: Lionel B. Ivashkiv, et al. Nat Rev Immunol. ;14(1):36-49.
pmc_ranked_result_index: '24433'
pathway_score: 0.9691911
filename: nihms594043f3.jpg
figtitle: Regulation of type I interferon responses
year: ''
organisms: Homo sapiens
ndex: f250fb2b-debd-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4084561__nihms594043f3.html
  '@type': Dataset
  description: 'Various receptor pathways cross-regulate the type I interferon (IFN)
    response; this alters the expression levels and activation states of IFN signalling
    components. Various mitogen-activated protein kinase (MAPK)-activating pathways,
    such as those induced by pattern-recognition receptors (PRRs), enhance signal
    transducer and activator of transcription 1 (STAT1) transcriptional activity through
    phosphorylation of a conserved carboxy-terminal serine. Low-level basal signalling
    by immunoreceptor tyrosine-based activation motif (ITAM)-containing receptors
    also augments Janus kinase 1 (JAK1) activity through activation of spleen tyrosine
    kinase (SYK) and protein tyrosine kinase 2 (PYK2). Conversely, strong activation
    of ITAM-containing receptors by high-avidity crosslinking suppresses IFNα receptor
    (IFNAR) signalling via protein kinase C (PKC)-mediated recruitment of SH2 domain-containing
    protein-tyrosine phosphatase 2 (SHP2), which dephosphorylates signalling intermediates.
    Cytokine signalling pathways, including the interleukin-1 (IL-1) pathway, inhibit
    type I IFN responses by directly promoting IFN receptor turnover via p38 kinase
    and casein kinase II (CK2). Various cytokines that signal through JAK–STAT pathways,
    including type I IFNs, regulate the expression levels of both positive and negative
    regulators of the IFN response pathways. JAK–STAT-induced positive regulators
    include STAT1 and IFN-regulatory factor 9 (IRF9), whereas negative regulators
    include the suppressor of cytokine signalling (SOCS) protein family and ubiquitin
    carboxy-terminal hydrolase 18 (USP18). Inhibitor of NF-κB kinase-ε (IKKε)-mediated
    STAT1 phosphorylation inhibits STAT1 homodimerization, thereby promoting activation
    of the IFN-stimulated gene factor 3 (ISGF3) complex rather than STAT1 homodimers
    in response to type I IFN. IKKε expression is induced by various pathways, including
    tumour necrosis factor (TNF)- and PRR-induced pathways. MicroRNAs induced by cytokine
    and PRR pathways downregulate the expression of IFN response signalling proteins:
    for example, miR-146a suppresses STAT1 expression, and miR-155 causes a collective
    reduction in various IFN signalling proteins. AGO2, Argonaute 2; RISC, RNA-induced
    silencing complex.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CSNK2A1
  - PRKCQ
  - PRKCG
  - STAT1
  - PRKCA
  - PRKCB
  - PRKCZ
  - IFNB1
  - PRKCH
  - PRKCI
  - IFNA16
  - PRKCD
  - PRKCE
  - IFNA17
  - PRKD3
  - IFNA5
  - USP18
  - STAT2
  - IFNA4
  - IFNA14
  - CISH
  - IFNA2
  - CSNK2A2
  - SYK
  - IL1A
  - IKBKE
  - JAK1
  - MAPK14
  - IRF9
  - TYK2
  - IFNA13
  - SCPEP1
  - IFNA10
  - TNF
  - AGO2
  - IL1B
  - IFNA21
  - PTPN11
  - PTK2B
  - IFNA1
  - IFNA8
  - MAPK13
  - MAPK12
  - MAPK11
  - IFNA6
  - IFNA7
  - CSNK2B
genes:
- word: p38,CK2
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2A1
  entrez: '1457'
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: ISGF3
  symbol: ISGF-3
  source: hgnc_alias_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: IFNa/IFNB
  symbol: IFNB
  source: bioentities_symbol
  hgnc_symbol: IFNB1
  entrez: '3456'
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: IFNa/IFNB
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA16
  entrez: '3449'
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: IFNa/IFNB
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA17
  entrez: '3451'
- word: PKC,
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: IFNa/IFNB
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA5
  entrez: '3442'
- word: USP18
  symbol: USP18
  source: hgnc_symbol
  hgnc_symbol: USP18
  entrez: '11274'
- word: STAT2
  symbol: STAT2
  source: hgnc_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: IFNa/IFNB
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA4
  entrez: '3441'
- word: IFNa/IFNB
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA14
  entrez: '3448'
- word: SOCS
  symbol: SOCS
  source: hgnc_alias_symbol
  hgnc_symbol: CISH
  entrez: '1154'
- word: IFNa/IFNB
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA2
  entrez: '3440'
- word: p38,CK2
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2A2
  entrez: '1459'
- word: SYK
  symbol: SYK
  source: hgnc_symbol
  hgnc_symbol: SYK
  entrez: '6850'
- word: IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1A
  entrez: '3552'
- word: STAT1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: IKKE
  symbol: IKKE
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKE
  entrez: '9641'
- word: JAK1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: p38,CK2
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: IRF9
  symbol: IRF9
  source: hgnc_symbol
  hgnc_symbol: IRF9
  entrez: '10379'
- word: TYK2
  symbol: TYK2
  source: hgnc_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: IFNa/IFNB
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA13
  entrez: '3447'
- word: RISC
  symbol: RISC
  source: hgnc_alias_symbol
  hgnc_symbol: SCPEP1
  entrez: '59342'
- word: IFNa/IFNB
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA10
  entrez: '3446'
- word: -TNF
  symbol: TNF
  source: hgnc_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: AGO2
  symbol: AGO2
  source: hgnc_symbol
  hgnc_symbol: AGO2
  entrez: '27161'
- word: IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: IFNa/IFNB
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA21
  entrez: '3452'
- word: PKC,SHP2
  symbol: SHP-2
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN11
  entrez: '5781'
- word: PYK2,
  symbol: PYK2
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2B
  entrez: '2185'
- word: IFNa/IFNB
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: IFNa/IFNB
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA8
  entrez: '3445'
- word: p38,CK2
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: p38,CK2
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: IFN
  symbol: IFN
  source: hgnc_alias_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: p38,CK2
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: IFNa/IFNB
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA6
  entrez: '3443'
- word: IFNa/IFNB
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA7
  entrez: '3444'
- word: p38,CK2
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2B
  entrez: '1460'
chemicals: []
diseases: []
---
